eMurmur Heart AI

by CSD Labs  · Based in Austria →Auscultation AI for healthier hearts & lungs.
Cardiology Internal Medicine Pulmonology

Contact for pricing.
Regulatory Status Disclosed

Overview

eMurmur Heart AI, developed by CSD Labs, is an advanced software platform designed to elevate the practice of auscultation by providing AI-powered analysis of heart and lung sounds. It functions as a clinical decision support tool, analyzing recorded heart sounds to identify the first (S1) and second (S2) heart sounds, and detect the presence or absence of abnormal heart murmurs. The platform also delivers hemodynamic insights by calculating the average loudness of individual heart sound components, including S1, systole, S2, and diastole, as well as their respective loudness ratios.

eMurmur is hardware-neutral and stethoscope agnostic, meaning it can be used with various commercially available digital stethoscopes, connecting via Bluetooth or audio cable to a mobile device or web portal. The system comprises a mobile app (iOS and Android) and a web portal, enabling clinicians to listen, record, stream, store, and analyze auscultation data. It supports both live listening during examinations and the capture and storage of recordings for later review, comparison over time, and remote consultation.

The AI-powered analysis aims to standardize auscultation, which has traditionally been subjective, and improve accuracy in screening for heart conditions. Clinical studies have demonstrated high sensitivity and specificity in differentiating pathologic from innocent heart murmurs. The platform offers features like PDF report generation and integration into electronic patient files and hospital information systems. Beyond heart sounds, eMurmur’s AI suite also provides detection of lung sound crackles and wheezes.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes)
  • Detection and classification of pathologic and innocent heart murmurs
  • Hemodynamic insights (loudness ratios of S1, systole, S2, diastole)
  • Mobile app (iOS, Android) and web portal for access
  • Hardware-neutral and stethoscope agnostic platform compatibility
  • Live streaming and remote auscultation for telehealth
  • Recording, secure storage, and playback of auscultation data
  • Comparison of current and previous auscultation data for monitoring
  • PDF report generation and EHR/EMR integration
  • AI-powered clinical decision support

Use Cases

  • Early and ongoing heart-health screening (pediatric, adult, elderly)
  • Primary and specialty care auscultation support
  • Telehealth and virtual visits for remote patient exams
  • Pharmacy and community-based heart health screenings
  • Home-health applications for remote monitoring
  • Medical education and training for auscultation skills

What Physicians Need to Know

Evidence Base
eMurmur Heart AI is built upon extensive research, partnering with international academic institutions since 2016. Its algorithms are developed and validated through clinical trials, with multiple academic publications available on platforms like Google Scholar, PubMed, and Up-to-Date. The AI model is trained using diverse patient data to ensure adaptability across various clinical environments.
Clinical Validation Studies
The tool has undergone significant clinical validation, including a virtual clinical trial on the Johns Hopkins Cardiac Auscultatory Recording Database (CARD) of 3,180 heart sound recordings, demonstrating 93% sensitivity and 81% specificity for pathologic cases, with 88% accuracy. A pilot study in 106 children showed 87% sensitivity and 100% specificity in differentiating pathologic from innocent murmurs. Overall, validation studies involving approximately 1,000 patients across the US, Canada, and Europe reported around 90% sensitivity and specificity against cardiologist interpretation and echocardiography. eMurmur Heart AI is FDA cleared (Class II medical device) and CE marked.
Alert Fatigue Management
As a clinical decision support system, eMurmur Heart AI is designed to augment, not replace, clinical judgment. It provides a 'Heart AI Score' to indicate recording reliability, helping clinicians prioritize and focus on high-quality data, thereby potentially reducing unnecessary alerts.
Override Rate Data
Specific override rate data is not publicly available. However, the system is explicitly intended to 'support clinician interpretation rather than replace clinical judgment,' and its interpretations are 'only significant when considered in conjunction with healthcare provider over-read and including all other relevant patient data.'
Differential Diagnosis Support
eMurmur Heart AI aids differential diagnosis by identifying the presence or absence of abnormal heart murmurs and distinguishing between physiological (innocent) and pathological murmurs, particularly in pediatric populations. It also provides objective data such as heart rate, S1/S2 heart sound identification, and relative intensity of systolic and diastolic phases.
Clinical Workflow Integration
The platform is web-based, accessible via computers, tablets, and mobile devices, and is compatible with various digital stethoscopes (hardware-agnostic). It supports live auscultation, recording, storage, and analysis of heart sounds. An eConsult workflow facilitates asynchronous specialist review, and PDF reports can be generated for integration into EHR/HIS. It can be accessed through standalone software or secure API integration into third-party systems. The analysis process is efficient, typically returning results within two seconds.
Decision Audit Trail
The platform is designed to capture, store, and allow comparison of auscultation sounds over time. This includes recordings and analysis results, which can be retrieved as PDF reports and integrated into electronic patient files, thereby creating a documented audit trail of the AI's analysis and the patient's heart sound history.
Physician Tip

Utilize eMurmur Heart AI as a robust screening and decision support tool, especially for differentiating innocent from pathological murmurs. Leverage its objective data (heart rate, S1/S2, murmur characteristics) to complement your clinical assessment. Integrate the AI score and recording quality indicators into your workflow to ensure reliable interpretations. The eConsult feature can streamline specialist referrals by providing comprehensive, recorded auscultation data for review.

eMurmur Heart AI offers flexible integration options, including standalone web and mobile applications, and secure API integration for third-party systems. Its hardware-agnostic design allows compatibility with various digital stethoscopes. The ability to generate PDF reports and integrate with EHR/HIS facilitates seamless data flow and documentation within existing clinical IT infrastructure.

Details

Category Cardiology AI, Telehealth & Virtual Care
Pricing Contact for pricing. Contact for pricing.
DeploymentCloud-based, Web application, Mobile app
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

eMurmur Heart AI is a Class II medical device cleared by the U.S. FDA 510(k) process (K252284). It performs automated heart sound analysis to identify S1 and S2 heart sounds, and detect the presence or absence of abnormal heart murmurs, including hemodynamic insights. It is intended as a decision support system for healthcare providers and not a sole means of diagnosis, cleared for use with any supported stethoscope.

Integrations
EHR Not specified
Specialties Cardiology, Internal Medicine, Pulmonology

What the Web Says

eMurmur Heart AI is a software platform that uses artificial intelligence to analyze heart sounds recorded by digital stethoscopes, aiming to improve the detection and classification of heart murmurs. It functions as a clinical decision support tool, providing automated analysis of heart sounds, identifying S1 and S2, and detecting the presence or absence of abnormal murmurs. The platform is FDA-cleared as a Class II medical device and is designed to support, not replace, clinical judgment.

Overall: Positive

Strengths

  • High accuracy in detecting and classifying heart murmurs, with reported sensitivities and specificities around 90% in validation studies.
  • Enhances diagnostic confidence and accuracy for healthcare providers, especially in telehealth settings and for non-specialists.
  • Compatible with multiple digital stethoscope models, offering flexibility and avoiding vendor lock-in.
  • Supports various use cases, including bedside auscultation, remote exams, community screenings, and integration into EHRs.
  • Provides visual and auditory playback of heart sounds, which is valuable for patient education and collaborative care.
  • Can reduce unnecessary referrals and identify more patients with mild or moderate/severe heart valve disease, as shown in a case study with community pharmacies.

Limitations

  • Some healthcare providers may perceive high-tech solutions as unnecessary, preferring traditional stethoscopes.
  • Requires compatible device operating systems and browser compatibility, which may necessitate IT considerations for deployment.
  • The platform's advanced features, like structured storage and AI analysis, may be more beneficial in cardiology consult workflows than in primary care telehealth visits.
  • Clinical acceptance of AI-assisted auscultation has been limited due to a lack of objective performance data in the past, though eMurmur has conducted validation studies.
  • The heart sound interpretations are intended as decision support and are only significant when considered with a healthcare provider's over-read and other patient data, not as a sole means of diagnosis.

Based on reviews from: eMurmur Platform: Web-Based Cardiac Sound Analysis and Collaboration, FDA Clears AI-Powered Heart Murmur Detection Software | Medical Product Outsourcing, Pilot Study Results Support Efficacy of eMurmur Computer-Aided Auscultation Platform, Uncovering the invisible patients with heart valve disease - eMurmur, Case study eMurmur auscultation software enhances clinical confidence and diagnostic accuracy for Duke telehealth providers, Hey Doc, What's That Sound? FDA Clearance Broadens Scope Of AI Heart Murmur Detection Platform - Citeline Insights, Artificial Intelligence-Assisted Auscultation of Heart Murmurs: Validation by Virtual Clinical Trial - eMurmur, K220766 - Allison Komiyama - accessdata.fda.gov, FDA clears first AI-powered mobile app to catch heart murmurs | Fierce Biotech, eMurmur - App Store - Apple, December 19, 2025 Csd Labs Allison Komiyama VP, MedTech Innovation Rqm+ 2790 Mosside Blvd. #800 Monroeville, Pennsylvania 14, Deep Learning Algorithms to Detect Murmurs Associated With Structural Heart Disease - PMC, AI-Enhanced Detection of Heart Murmurs: Advancing Non-Invasive Cardiovascular Diagnostics - PMC, How to Use Al to Improve Heart Murmur Screening 4X with eMurmur - YouTube

Last updated: 2026-07-21

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate eMurmur Heart AI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Medical Product Outsourcing
FDA Clears AI-Powered Heart Murmur Detection Software
eMurmur has received its third FDA 510(k) clearance for a suite of AI algorithms that evaluate heart recordings from digital stethoscopes, enabling detection of abnormal heart murmurs and hemodynamic insights across various supported stethoscopes.
2026-03
PR Newswire
eMurmur's Open Medical AI Receives FDA Clearance, Enabling Murmur Detection Across Digital Stethoscope Models and Third-Party Software
eMurmur, an AI startup specializing in medical AI for analyzing heart and lung sounds, announced its newly FDA-cleared Heart AI suite, which identifies primary heart sounds and detects abnormal heart murmurs, and provides hemodynamic insights.
2026-01
Citeline Insights
Hey Doc, What's That Sound? FDA Clearance Broadens Scope Of AI Heart Murmur Detection Platform
The US FDA has granted clearance to eMurmur, broadening the use of its AI-powered software platform to identify primary heart sounds and detect abnormal murmurs, now compatible with any supported stethoscope.
2026-01
eMurmur (News section)
eMurmur Heart AI project wins UK Independent Community Pharmacy Awards in the innovation category.
eMurmur Heart AI project won the UK Independent Community Pharmacy Awards in the innovation category for its pioneering pilot in early detection and diagnosis of valve disease using digital stethoscopes and AI technology in a community pharmacy setting.
2023-10
eMurmur (Publications section)
eMurmur Heart AI enables detection of heart valve disease in the community pharmacy setting.
A December 2023 publication highlights how eMurmur Heart AI facilitates the detection of heart valve disease in community pharmacies, enabling pharmacists to identify abnormal heart sounds and support referral decisions.
2023-12
PMC (BMJ Open)
Developing an AI-assisted digital auscultation tool for automatic assessment of the severity of mitral regurgitation: protocol for a cross-sectional, non-interventional study
This study protocol details the development of a deep neural network-based cardiac auscultation method for assessing mitral regurgitation severity, noting eMurmur Heart AI's 2019 FDA clearance for murmur detection.
2024-03
DAIC
eMurmur Open Digital Stethoscope Now Available in the U.S.
eMurmur announced the availability of its open software platform for advanced digital auscultation in the U.S., making improved screening for heart, lung, and bowel health accessible to hardware and telehealth providers.
2021-11
Fierce Biotech
FDA clears first AI-powered mobile app to catch heart murmurs
In May 2019, the FDA cleared eMurmur's mobile-based solution that uses AI to detect and classify heart murmurs with a digital stethoscope, offering greater accuracy in screening.
2019-05

Videos

Product demos, reviews, and walkthroughs for eMurmur Heart AI.

Loading videos...

View all on YouTube

Frequently Asked Questions

eMurmur Heart AI is a clinical decision support tool that analyzes recorded heart sounds to identify the presence or absence of abnormal murmurs, detect key cardiac components like S1 and S2, and measure heart rate and the relative intensity of systolic and diastolic phases. It provides clinicians with AI-assisted insights to support their interpretation during auscultation review.
Yes, eMurmur Heart AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance as a Class II medical device. It also holds CE markings for use in the European Union, demonstrating its compliance with international medical device regulations.
eMurmur Heart AI is intended as a clinical decision support system and not as a sole means of diagnosis. Its heart sound interpretations are significant only when considered in conjunction with a healthcare provider's over-read and all other relevant patient data.
Yes, eMurmur Heart AI is designed to be hardware-agnostic, supporting multiple types of digital stethoscopes. It can be accessed through its standalone web platform or mobile app, or via secure API integration into third-party systems, which facilitates potential integration with electronic health record (EHR) systems.
Validation studies involving approximately 1,000 patients have reported eMurmur Heart AI to have around 90% sensitivity and specificity when compared with cardiologist interpretation and echocardiography reference standards. Other studies indicate a sensitivity of 93% and specificity of 81% for detecting pathologic murmurs.
eMurmur Heart AI supports a wide range of clinical applications, including bedside auscultation, remote stethoscope exams during virtual visits, and screenings in pharmacy or community settings. It is also valuable for cardiology consult workflows, clinical documentation, and educational purposes in teaching environments.
eMurmur offers various marketed versions of its platform, including Basic, Pro, Telehealth, and Enterprise levels. Specific pricing schedules are associated with these different tiers, and detailed information would typically be obtained through direct inquiry.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

More from CSD Labs

eMurmur ID
CSD Labs GmbH
Cardiology AI
AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.